BECN1 and nasopharyngeal carcinoma: In contrast, other groups discovered that increased Beclin-1 expression was correlated with unfavorable outcome in oral squamous cell carcinoma [35], nasopharyngeal carcinoma [36], and pancreatic ductal adenocarcinoma [37].